Skip to Main Content
Skip Nav Destination

New biomaterials are now entering clinical application in a range of applications from cell-free implants to combination biomaterial–therapeutic cells, biomaterial–drug combinations, and more. While regulatory guidelines are continuously evolving, here we discuss several general concepts that will help in navigating the regulatory and translational pathways in developing bioengineered scaffolds, implants and injectables for therapeutic use in the eye.

You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Don't already have an account? Register

or Create an Account

Close Modal
Close Modal